Hostname: page-component-7b7567c8c-slfcl Total loading time: 0 Render date: 2026-11-19T12:51:58.691Z Has data issue: false hasContentIssue false

sperm-based contraceptive vaccines: current status, merits and development

Published online by Cambridge University Press:  12 September 2005

anil suri
Affiliation:
genes and proteins laboratory, national institute of immunology, aruna asaf ali marg, new delhi 110067, india.
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

at the present growth rate, the world population is estimated to reach a phenomenal 8.9 billion people by the year 2050, posing a great risk of overpopulation. therefore, new strategies of contraception are required. a novel contraceptive strategy that is receiving considerable attention is that of immunocontraception. spermatozoa have proteins that are unique, cell specific, immunogenic and accessible to antibodies. the targeting of antibodies to gamete-specific antigens implicated in sperm function, sperm–egg binding and fertilisation could block sperm binding and thus fertilisation. the present review highlights the current status, relative merits and future directions for various sperm-based candidate antigens with regard to the development of a contraceptive vaccine.

Information

Type
Review Article
Copyright
cambridge university press 2005